Baidu
map

Neurology:紫绀型先天性心脏病的婴幼儿常发生动脉缺血性卒中

2015-09-29 phylis 译 MedSci原创

目的:为了描述患有心脏病并且发生动脑缺血性卒中(AIS)儿童的心脏疾病谱,及时干预以及患者的预后。方法:收集1993年到2010年间,墨尔本皇家儿童医院患有心脏病并且影像学证实AIS的小于18岁儿童。结果:患有心脏病且影像学诊断为AIS的儿童76名,年龄的中位数为5个月(四分卫间距0-58)。心脏损伤包括紫绀型先天性心脏病(CHD)42名(55%),非紫绀型心脏病24名(29%),心肌疾病/心肌炎

目的:为了描述患有心脏病并且发生动脉缺血性卒中(AIS)儿童的心脏疾病谱,及时干预以及了解患者的预后。

方法:收集1993年到2010年间,墨尔本皇家儿童医院患有心脏病并且影像学证实小于18岁的AIS儿童。

结果:患有心脏病且影像学诊断为AIS的儿童76名,年龄的中位数为5个月(四分位间距0-58)。心脏损伤包括紫绀型先天性心脏病(CHD)42名(55%),非紫绀型心脏病24名(29%),心肌疾病/心肌炎6名(8%)感染性心内膜炎3名(4%),原因不明心律失常3名(4%)。对心脏进行手术治疗后发生卒中的患者52名(68%):41名心脏手术后(4.6名卒中/1000个手术),11名心导管检查术后(1.7名卒中/1000导管检查术后)。从进行操作到诊断为卒中时间的中位数为3天(四分位间距2-7),68%(95%CI: 58%-79%)的卒中发生在围手术期。围手术期卒中的发生随着诊断标准的变化而变化,但接受姑息性手术治疗的紫绀型先天性心脏病最常见(22/2256,1%)。3名患者因AIS死亡,54名(85%)存活者存在永久性神经功能障碍。

结论:在围手术期,患有紫绀型先天性心脏病的婴儿最常发生AIS。需要进行前瞻性的队列研究确定有效的一级、二级预防措施。

原文出处:

Asakai H, Cardamone M, Hutchinson D,et al. Arterial ischemic stroke in children with cardiac disease. Neurology. 2015 Sep 25.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999572, encodeId=17e119995e2b8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jul 13 06:23:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892685, encodeId=8c0818926859a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 10 23:23:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806036, encodeId=0d111806036d3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Aug 27 05:23:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776305, encodeId=0e681e7630579, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Sun Mar 13 14:23:00 CST 2016, time=2016-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369211, encodeId=afc313692116f, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Oct 01 00:23:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
    2016-07-13 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999572, encodeId=17e119995e2b8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jul 13 06:23:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892685, encodeId=8c0818926859a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 10 23:23:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806036, encodeId=0d111806036d3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Aug 27 05:23:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776305, encodeId=0e681e7630579, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Sun Mar 13 14:23:00 CST 2016, time=2016-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369211, encodeId=afc313692116f, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Oct 01 00:23:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999572, encodeId=17e119995e2b8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jul 13 06:23:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892685, encodeId=8c0818926859a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 10 23:23:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806036, encodeId=0d111806036d3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Aug 27 05:23:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776305, encodeId=0e681e7630579, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Sun Mar 13 14:23:00 CST 2016, time=2016-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369211, encodeId=afc313692116f, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Oct 01 00:23:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1999572, encodeId=17e119995e2b8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jul 13 06:23:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892685, encodeId=8c0818926859a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 10 23:23:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806036, encodeId=0d111806036d3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Aug 27 05:23:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776305, encodeId=0e681e7630579, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Sun Mar 13 14:23:00 CST 2016, time=2016-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369211, encodeId=afc313692116f, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Oct 01 00:23:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1999572, encodeId=17e119995e2b8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Jul 13 06:23:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892685, encodeId=8c0818926859a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Feb 10 23:23:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806036, encodeId=0d111806036d3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Aug 27 05:23:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776305, encodeId=0e681e7630579, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Sun Mar 13 14:23:00 CST 2016, time=2016-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369211, encodeId=afc313692116f, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Oct 01 00:23:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
    2015-10-01 huirong

相关资讯

JCO:曲妥单抗增加心脏病风险

 由于曲妥单抗用于人表皮生长因子受体2(HER2)阳性早期乳腺癌治疗的辅助化疗,患者的生存结果出现了显著的改善。但是,曲妥单抗有可能会增加心脏毒性的风险,因此对于发病率和风险因素的长期评价是很有必要的。 NCCTG N9831试验比较了HER2阳性乳腺癌患者使用辅助的阿霉素和环磷酰胺(AC),随后每周使用紫杉醇(A组);紫杉醇然后曲妥单抗(B组);或者是紫杉醇加曲妥单抗随后单独

SCAND J PRIM HEALTH :女性适度饮用啤酒可降低心脏病的发病风险

据瑞典的一项研究表明,与重度饮酒及从不饮酒女性的相比,每周饮用一次或两次啤酒的女性,其心脏病的发病风险可降低30%。

黄浙勇:开辟靶向治疗新战场 ——磁感应定向调控干细胞治疗心脏病

黄浙勇复旦大学附属中山医院 2014年明治生命科学奖获得者。发表SCI 收录论文28篇,包括以第一作者发表于Biamterials的论文3篇。受邀参编英文专著Nano Based Drug Delivery,参编中文专著14部。申请国家发明专利2项,获得新型实用专利1项。曾获教育部科技进步奖、教育部科技推广奖、中国实验动物学会科技奖、上海医学科技奖。 一、细胞靶向归巢的重要性

心脏病发作前,就应该知道的8件事!

把34岁的迪拜王子带走的心脏病是怎么来的?避免心脏病发作首先应该从预防做起,如果有以下危险因素,就要小心了!壹高血压根据2010年全球疾病负担研究,中国每年由于血压升高而导致的过早死亡人数高达200万,每年直接医疗费用达366亿元人民币。中国18岁以上成人高血压患病率为18.8%。北方地区高于南方,部分北方地区高达30%以上。中国18岁以上居民正常高值血压检出率为34%,男性高于女性,正常高值

地中海饮食防治中年人心脑血管病 可与他汀相媲美

为了控制疾病风险,具有卒中或心脏病风险患者应采用地中海饮食,而不是一味的接受他汀治疗。这一观点正得到越来越多医学专家的认可。在最近发表的一篇声明中,众多专家一致呼吁患者健康饮食、积极运动、停止吸烟,这些生活干预方式与降脂药物治疗同样重要。另外包括英国卫生质量标准署(NICE)在内的医学团队应减少“药物治疗防控风险”的依赖性。参与该声明的专家认为,医生应为患者提供有关他汀治疗利弊的更多信息,并给出一

集容貌财富权利于一体的迪拜酋长长子突发心脏病去世,年仅34岁

迪拜酋长长子据当地媒体19日消息,阿联酋迪拜酋长长子拉希德•穆罕默德•拉希德•马克图姆突发心脏病去世,年仅34岁。拉希德是迪拜酋长谢赫穆罕默德最年长的儿子,为迪拜多家投资公司、银行主要合伙人,曾被福布斯评为全球最热门年轻皇室成员之一,还多次获国际耐力赛奖项。警示:集容貌财富权利于一体的迪拜王子,突发心脏病去世了!不要说你很有钱,也不要说你很年轻,疾病面前人人平等,不要以年轻为资本,健康重视从年轻就

Baidu
map
Baidu
map
Baidu
map